Modulation of NMDA receptor at the synapse: Promising therapeutic interventions in disorders of the nervous system-Reference-Cited by-同舟云学术

Modulation of NMDA receptor at the synapse: Promising therapeutic interventions in disorders of the nervous system

Published:2013-11 Issue:1-3 Volume:719 Page:75-83
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Mellone Manuela,Gardoni Fabrizio

Funder

Cariplo Foundation

PRIN 2010–2011

Publisher

Elsevier BV

Subject

Pharmacology

Reference101 articles.

1. Treatment of ischemic brain damage by perfusing NMDA receptor-PSD-95 protein interactions;Aarts;Science,2002

2. UCCB01-125, a dimeric inhibitor of PSD-95, reduces inflammatory pain without disrupting cognitive or motor performance: comparison with the NMDA receptor antagonist MK-801;Andreasen;Neuropharmacol.,2012

3. Cell-permeable and plasma-stable peptidomimetic inhibitors of the postsynaptic density-95/N-methyl-D-aspartate receptor interaction;Bach;J. Med. Chem.,2011

4. Update on the neurophysiology of pain transmission and modulation: focus on the NMDA receptor;Bennett;J. Pain Symptom Manage.,2000

5. The death-associated protein kinases: structure, function, and beyond;Bialik;Ann. Rev. Biochem.,2006

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NMDA Receptor Antagonists: Emerging Insights into Molecular Mechanisms and Clinical Applications in Neurological Disorders;Pharmaceuticals;2024-05-15

2. Practical Three-Component Regioselective Synthesis of Drug-Like 3-Aryl(or heteroaryl)-5,6-dihydrobenzo[h]cinnolines as Potential Non-Covalent Multi-Targeting Inhibitors To Combat Neurodegenerative Diseases;ACS Chemical Neuroscience;2024-04-22

3. Addressing the Neuroprotective Actions of Coffee in Parkinson’s Disease: An Emerging Nutrigenomic Analysis;Antioxidants;2022-08-16

4. SAGE-718: A First-in-Class N-Methyl-D-Aspartate Receptor Positive Allosteric Modulator for the Potential Treatment of Cognitive Impairment;J MED CHEM;2022

5. SAGE-718: A First-in-Class N-Methyl-d-Aspartate Receptor Positive Allosteric Modulator for the Potential Treatment of Cognitive Impairment;Journal of Medicinal Chemistry;2022-07-02